Emergence of resistance to carbapenems in Acinetobacter baumannii in Europe: clinical impact and therapeutic options
- 1 February 2012
- journal article
- review article
- Published by Elsevier BV in International Journal of Antimicrobial Agents
- Vol. 39 (2), 105-114
- https://doi.org/10.1016/j.ijantimicag.2011.10.004
Abstract
No abstract availableKeywords
This publication has 100 references indexed in Scilit:
- Impaired Virulence and In Vivo Fitness of Colistin-Resistant Acinetobacter baumanniiThe Journal of Infectious Diseases, 2011
- Carbapenem-Hydrolyzing GES-Type Extended-Spectrum β-Lactamase in Acinetobacter baumanniiAntimicrobial Agents and Chemotherapy, 2011
- Colistin Resistance in Acinetobacter baumannii Is Mediated by Complete Loss of Lipopolysaccharide ProductionAntimicrobial Agents and Chemotherapy, 2010
- Changing carbapenemase gene pattern in an epidemic multidrug-resistant Acinetobacter baumannii lineage causing multiple outbreaks in central ItalyJournal of Antimicrobial Chemotherapy, 2010
- Extended-Spectrum Cephalosporinase in Acinetobacter baumanniiAntimicrobial Agents and Chemotherapy, 2010
- Diversity, Epidemiology, and Genetics of Class D β-LactamasesAntimicrobial Agents and Chemotherapy, 2010
- Resistance to Colistin in Acinetobacter baumannii Associated with Mutations in the PmrAB Two-Component SystemAntimicrobial Agents and Chemotherapy, 2009
- GES-11, a Novel Integron-Associated GES Variant in Acinetobacter baumanniiAntimicrobial Agents and Chemotherapy, 2009
- Emergence and spread of carbapenem-resistant Acinetobacter baumannii in a tertiary care hospital in TurkeyFEMS Microbiology Letters, 2008
- Emergence of PER-2 and VEB-1a in Acinetobacter baumannii Strains in the AmericasAntimicrobial Agents and Chemotherapy, 2006